Who has invested in Nereid Therapeutics?

Apple Tree Partners are named among the investors backing Nereid Therapeutics.

Nereid Therapeutics Funding: $50M Raised, Series A (2020)

Nereid Therapeutics funding overview

Nereid Therapeutics is based in Cambridge. Nereid Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2020. The round record for Nereid Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Apple Tree Partners.

Nereid Therapeutics at a glance

Total raised: $50M
Latest round: Series A
Latest round date: November 2020
Headquarters: Cambridge
Notable investors: Apple Tree Partners

Frequently asked about Nereid Therapeutics funding

How much has Nereid Therapeutics raised?: Nereid Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Nereid Therapeutics?: Apple Tree Partners are named among the investors backing Nereid Therapeutics.
What was the latest Nereid Therapeutics funding round?: The most recent disclosed round is a Series A, announced in November 2020.
Where is Nereid Therapeutics based?: Nereid Therapeutics is based in Cambridge.
When did Nereid Therapeutics last raise?: The last disclosed Nereid Therapeutics round closed in November 2020 at Series A.

Round data for Nereid Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.

Nereid Therapeutics Funding: $50M Raised, Series A (2020)

Nereid Therapeutics funding overview

Nereid Therapeutics at a glance

Frequently asked about Nereid Therapeutics funding

Companies related to Nereid Therapeutics (31)

Browse related funding lists (6)